Zogenix is a specialty pharmaceutical company developing and commercialising medicines to treat disorders of the central nervous system. Zogenix developed needle free delivery of sumatriptan, which is now marketed in the US and Europe for the treatment of cluster headaches and migraine. The company went public in November 2010.

LocationSan Diego, California
Websitewww.zogenix.com